JiangXi Tianxin Pharm Co Ltd (603235) — Working Capital to Net Assets Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Working Capital to Net Assets ratio of 44.3% as of March 2026. Working capital of CN¥2.24 Billion (current assets of CN¥2.79 Billion minus current liabilities of CN¥549.73 Million) is measured against net assets of CN¥5.06 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can JiangXi Tianxin Pharm Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
JiangXi Tianxin Pharm Co Ltd Working Capital to Net Assets (2020–2025)
This chart shows how JiangXi Tianxin Pharm Co Ltd's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 44.3%, reflecting working capital of CN¥2.24 Billion against net assets of CN¥5.06 Billion CNY. For the complete balance sheet picture, see JiangXi Tianxin Pharm Co Ltd asset portfolio.
Annual Working Capital to Net Assets for JiangXi Tianxin Pharm Co Ltd (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for JiangXi Tianxin Pharm Co Ltd from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check JiangXi Tianxin Pharm Co Ltd (603235) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.7% | CN¥2.15 Billion | CN¥4.92 Billion | CN¥2.78 Billion | CN¥635.59 Million | ▼ -3.7 pp |
| 2024 | 47.3% | CN¥2.19 Billion | CN¥4.62 Billion | CN¥2.70 Billion | CN¥509.78 Million | ▼ -15.5 pp |
| 2023 | 62.8% | CN¥2.66 Billion | CN¥4.23 Billion | CN¥3.12 Billion | CN¥461.33 Million | ▼ -7.5 pp |
| 2022 | 70.4% | CN¥2.86 Billion | CN¥4.06 Billion | CN¥3.17 Billion | CN¥311.18 Million | ▲ +23.1 pp |
| 2021 | 47.3% | CN¥902.34 Million | CN¥1.91 Billion | CN¥1.58 Billion | CN¥677.06 Million | ▲ +33.7 pp |
| 2020 | 13.5% | CN¥156.24 Million | CN¥1.15 Billion | CN¥1.65 Billion | CN¥1.49 Billion | — |